Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents

Aziz Nazha,Mikkael A. Sekeres,Guillermo Garcia-Manero,John Barnard,Najla H. Al Ali,Gail J. Roboz,David P. Steensma,Amy E. DeZern,Cassie Zimmerman,Elias J. Jabbour,Katrina Zell,Alan F. List,Hagop M. Kantarjian,Jaroslaw P. Maciejewski,Rami S. Komrokji

Leukemia Research（2016）

引用 31|浏览16

暂无评分

摘要

•Most MDS patients treated with HMA will achieve a BR by 4–6 months of therapy.•Patients who achieves CR after a SD status at 4–6 months have a longer OS.•A new strategies to improve responses after SD at 4–6 months should be explored.

查看译文

关键词

MDS,Response,Stable disease,Hypomethylating agent

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要